Home
/
CME GROUP INC.
/
Financials
/
Quarterly
CME GROUP INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CME GROUP INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.54B
Oct 24, 2025
Q2
2025
Jun 30, 2025
$1.69B
Jul 25, 2025
Q1
2025
Mar 31, 2025
$1.64B
Apr 30, 2025
Q3
2025
Sep 30, 2024
$1.58B
Oct 24, 2025
Q2
2025
Jun 30, 2024
$1.53B
Jul 25, 2025
Q1
2025
Mar 31, 2024
$1.49B
Apr 30, 2025
Q3
2024
Sep 30, 2023
$1.34B
Nov 8, 2024
Q2
2024
Jun 30, 2023
$1.36B
Aug 5, 2024
Q1
2024
Mar 31, 2023
$1.44B
May 1, 2024
Q3
2023
Sep 30, 2022
$1.23B
Nov 1, 2023
Q2
2023
Jun 30, 2022
$1.24B
Aug 2, 2023
Q1
2023
Mar 31, 2022
$1.35B
May 3, 2023
Q3
2022
Sep 30, 2021
$1.11B
Nov 2, 2022
Q2
2022
Jun 30, 2021
$1.18B
Aug 3, 2022
Q1
2022
Mar 31, 2021
$1.25B
May 4, 2022
Q3
2021
Sep 30, 2020
$1.08B
Nov 3, 2021
Q2
2021
Jun 30, 2020
$1.18B
Aug 5, 2021
Q1
2021
Mar 31, 2020
$1.52B
May 5, 2021
Q3
2020
Sep 30, 2019
$1.28B
Nov 4, 2020
Q2
2020
Jun 30, 2019
$1.27B
Aug 5, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2022
Sep 30, 2022
$679.60M
Nov 2, 2022
Q2
2022
Jun 30, 2022
$662.50M
Aug 3, 2022
Q1
2022
Mar 31, 2022
$711.00M
May 4, 2022
Q3
2022
Sep 30, 2021
$926.50M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$510.30M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$574.40M
May 4, 2022
Q3
2021
Sep 30, 2020
$411.70M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$503.30M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$766.20M
May 5, 2021
Q3
2020
Sep 30, 2019
$636.30M
Nov 4, 2020
Q2
2020
Jun 30, 2019
$513.80M
Aug 5, 2020
Q1
2020
Mar 31, 2019
$496.90M
May 6, 2020
Q3
2019
Sep 30, 2018
$411.80M
Nov 6, 2019
Q2
2019
Jun 30, 2018
$566.10M
Aug 7, 2019
Q1
2019
Mar 31, 2018
$598.80M
May 8, 2019
Q3
2017
Sep 30, 2017
$1.12B
Nov 2, 2017
Q2
2017
Jun 30, 2017
$815.60M
Aug 2, 2017
Q1
2017
Mar 31, 2017
$399.80M
May 4, 2017
Q3
2017
Sep 30, 2016
$1.16B
Nov 2, 2017
Q2
2017
Jun 30, 2016
$687.90M
Aug 2, 2017
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$972.60M
Oct 24, 2025
Q2
2025
Jun 30, 2025
$1.13B
Jul 25, 2025
Q1
2025
Mar 31, 2025
$1.11B
Apr 30, 2025
Q3
2025
Sep 30, 2024
$1.02B
Oct 24, 2025
Q2
2025
Jun 30, 2024
$1.00B
Jul 25, 2025
Q1
2025
Mar 31, 2024
$959.60M
Apr 30, 2025
Q3
2024
Sep 30, 2023
$820.20M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$838.60M
Aug 5, 2024
Q1
2024
Mar 31, 2023
$913.70M
May 1, 2024
Q3
2023
Sep 30, 2022
$738.80M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$749.70M
Aug 2, 2023
Q1
2023
Mar 31, 2022
$859.10M
May 3, 2023
Q3
2022
Sep 30, 2021
$613.70M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$674.70M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$725.10M
May 4, 2022
Q3
2021
Sep 30, 2020
$525.00M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$637.50M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$959.90M
May 5, 2021
Q3
2020
Sep 30, 2019
$685.20M
Nov 4, 2020
Q2
2020
Jun 30, 2019
$698.60M
Aug 5, 2020